| 11/13/2026 4:45 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Subject | Form 144/A | |
| 11/13/2026 4:46 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Subject | Form 144/A | |
| 11/12/2026 7:59 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 8:01 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 8:03 PM | Roivant Sciences (1635088) Issuer Torti Frank (1647805) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 6:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 6:01 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/12/2026 7:49 AM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/10/2026 4:07 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144/A | |
| 11/10/2026 4:07 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Subject | Form 144/A | |
| 11/10/2026 4:08 PM | Roivant Sciences (1635088) Subject Torti Frank (1647805) Reporting | Form 144/A | |
Get the Latest News and Ratings for ROIV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Roivant Sciences and its competitors with MarketBeat's FREE daily newsletter.
|
| 11/10/2026 3:36 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/10/2026 3:23 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/10/2026 3:23 PM | Roivant Sciences (1635088) Subject Torti Frank (1647805) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/10/2026 3:25 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/10/2026 3:28 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/09/2026 6:36 AM | Roivant Sciences (1635088) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/09/2026 6:17 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/05/2026 5:11 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2026 12:24 PM | FMR LLC (315066) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 10/30/2026 5:29 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/28/2026 3:35 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/27/2026 5:21 PM | MOMTAZEE JAMES C (1209181) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/27/2026 5:22 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/27/2026 5:23 PM | Oren Ilan (1643073) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2026 5:44 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/21/2026 6:05 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/20/2026 4:41 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/20/2026 4:42 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/20/2026 3:44 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/05/2026 8:00 PM | Arbutus Biopharma Corp (1447028) Issuer Roivant Sciences (1635088) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/05/2026 8:02 PM | Arbutus Biopharma Corp (1447028) Subject Roivant Sciences (1635088) Filed by | Form SCHEDULE 13D/A | |
| 10/05/2026 5:05 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2026 8:00 PM | Roivant Sciences (1635088) Issuer Torti Frank (1647805) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2026 8:00 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2026 4:38 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2026 4:37 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/30/2026 3:21 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/22/2026 8:00 PM | Humes Jennifer (2058012) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/22/2026 5:26 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 8:00 PM | MANCHESTER KEITH S (1244828) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
Why I'm selling my Snapback Indicator for just $7 (Ad) For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500.
The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long.
No strings attached, and Wood says there is an unusual reason behind the steep discount. Get lifetime access to the Snapback Indicator for a one-time $7 payment today. |
| 09/18/2026 6:12 PM | Gold Daniel Allen (1832142) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 5:56 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 5:57 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 6:01 PM | MOMTAZEE JAMES C (1209181) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 6:06 PM | Oren Ilan (1643073) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/18/2026 6:14 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/17/2026 5:42 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/17/2026 5:43 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 3:40 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/15/2026 3:32 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/14/2026 8:00 PM | Gold Daniel Allen (1832142) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/14/2026 5:42 PM | Oren Ilan (1643073) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/14/2026 5:25 PM | MOMTAZEE JAMES C (1209181) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/14/2026 5:29 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/14/2026 5:34 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/10/2026 8:00 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/08/2026 3:27 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/08/2026 8:15 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/01/2026 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/28/2026 3:33 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/27/2026 4:24 PM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/24/2026 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/24/2026 8:00 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2026 8:00 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/21/2026 3:20 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/20/2026 3:34 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/18/2026 8:00 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2026 3:29 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/17/2026 3:40 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 08/13/2026 2:45 PM | MORGAN STANLEY (895421) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 08/06/2026 6:28 AM | Roivant Sciences (1635088) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/06/2026 6:13 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/29/2026 8:00 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 8:00 PM | Oren Ilan (1643073) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 8:00 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/21/2026 8:00 PM | MOMTAZEE JAMES C (1209181) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 6:00 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 6:01 PM | Roivant Sciences (1635088) Issuer Torti Frank (1647805) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 6:03 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 6:06 PM | Gline Matthew (1750094) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/01/2026 5:34 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 7:38 PM | MANCHESTER KEITH S (1244828) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 7:30 PM | Gold Daniel Allen (1832142) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 6:59 PM | QVT Financial LP (1290162) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 3:36 PM | Fitzgerald Meghan (1349297) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/29/2026 5:23 PM | Roivant Sciences (1635088) Issuer Sukhatme Mayukh (1750050) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/29/2026 3:40 PM | Epperly Melissa B, (1807359) Reporting Roivant Sciences (1635088) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/26/2026 5:13 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2026 3:33 PM | Roivant Sciences (1635088) Subject Sukhatme Mayukh (1750050) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/24/2026 3:01 PM | Roivant Sciences (1635088) Subject Venker Eric (1801917) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Management just bought 2.8 million shares (Ad) Management just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 in one quarter.
Institutions own about 83% of shares, including BlackRock's 32 million shares worth $716 million and Vanguard's 48 million shares worth nearly $1.1 billion.
A new multi-year deal with Palantir adds an AI-driven edge to this energy producer's operations. Watch the briefing on this buyback and AI opportunity now |
| 06/23/2026 8:16 PM | Humes Jennifer (2058012) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/23/2026 8:17 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 5:25 PM | Roivant Sciences (1635088) Issuer Venker Eric (1801917) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/22/2026 5:22 PM | Pulik Richard (1885841) Reporting Roivant Sciences (1635088) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/20/2026 3:40 PM | Roivant Sciences (1635088) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 05/20/2026 6:14 AM | Roivant Sciences (1635088) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/20/2026 6:17 AM | Roivant Sciences (1635088) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 05/12/2026 12:19 PM | MORGAN STANLEY (895421) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |
| 05/06/2026 8:07 PM | Ramaswamy Vivek (1635075) Filed by Roivant Sciences (1635088) Subject | Form SCHEDULE 13G/A | |